Table 4.
Group | Pre-Treatment Period | Treatment Period | Post-Treatment Period | |||
---|---|---|---|---|---|---|
†SRWC (L/day) | ‡Daily PA (mins/day) | SRWC (L/day) | Daily PA (mins/day) | SRWC (L/day) | Daily PA (mins/day) | |
Control | ||||||
Women (n = 12) |
2.5 ± 0.2 (1.7 - 4.8) |
82 ± 9 (20 - 153) |
2.4 ± 0.3 (1.2 - 5.0) |
77 ± 12 (16 - 173) |
2.2 ± 0.2 (1.3 - 4.7) |
83 ± 12 (27 - 156) |
Men (n = 7) |
2.4 ± 0.4 (1.2 - 4.2) |
92 ± 5 (78 - 109) |
2.2 ± 0.4 (1.0 - 3.8) |
82 ± 11 (60 - 135) |
2.3 ± 0.5 (1.0 - 3.8) |
74 ± 10 (45 - 106) |
Entire Group (n = 19) |
2.5 ± 0.2 (1.2 - 4.8) |
85 ± 8 (20 - 153) |
2.4 ± 0.3 (1.0 - 5.0) |
78 ± 8 (16 - 173) |
2.2 ± 0.3 (1.0 - 4.7) |
80 ± 8 (27 - 156) |
Experimental | ||||||
Women (n = 13) |
2.0 ± 0.2 (1.0 - 4.1) |
74 ± 9 (12 - 128) |
1.9 ± 0.2 (1.0 - 4.0) |
58 ± 6 (29 - 93) |
1.7 ± 0.2 (1.0 - 3.0) |
74 ± 10 (40 - 166) |
Men (n = 6) |
3.1 ± 0.2 (2.1 - 4.0) |
105 ± 15 (41 - 170) |
2.8 ± 0.5 (1.1 - 5.8) |
91 ± 15 (15 - 127) |
3.4 ± 0.4 (2.0 - 5.8) |
92 ± 16 (47 - 145) |
Entire Group (n = 19) |
2.4 ± 0.2 (1.0 - 4.1) |
85 ± 6 (12 - 170) |
2.2 ± 0.2 (1.0 - 5.8) |
70 ± 8 (15 - 127) |
2.3 ± 0.2 (1.0 - 5.8) |
81 ± 8 (40 - 166) |
† SRWC = self-reported water consumption as recorded within food diaries.
‡ Daily PA = daily physical activity as determined with wrist-worn physical activity monitors.